CBMG Chart
- 52-Week Range: $10.98 - $18.99
- Market Capitalization: $279.62M
- Short Percentage: 0%
- Target Price: $19.00
- Shares Outstanding: 19.48M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
No upcoming catalysts found
News and Press Releases
- BTAI Investors Have Opportunity to Lead BioXcel Therapeutics, Inc. Securities Fraud LawsuitPRNewsWire | August 15th
- NeurAxis Announces Positive University of Michigan IB-Stim™ Cost Effectiveness Study at ANMS 2023GlobeNewsWire | August 15th
- Galecto shares drop 65% as biotech halts development of lung-disease treatmentMarket Watch | August 15th
- Microbot Medical Boosts Manufacturing and Commercialization Capabilities for its Robotic Surgical SystemGlobeNewsWire | August 15th
- Dexcom Canada Achieves Great Place to Work® Certification for Second Consecutive YearBusiness Wire | August 15th
- Cardinal Health Beats on Earnings, Raises Guidance on Strong Pharmaceutical SalesBarrons | August 15th
- AmerisourceBergen Elects Werner Baumann and Lauren Tyler to Its Board of DirectorsBusiness Wire | August 15th
We searched over 50 sources and couldn't find any news or press releases related to Cellular Biomedicine Group.
Here are some articles we think you might like.
Company Info
Website: http://www.cellbiomedgroup.com
Address: 1345 Avenue of Americas, New York, NY, United States, 10105
Sector: Healthcare
Industry: Biotechnology
Full time employees: 217
Address: 1345 Avenue of Americas, New York, NY, United States, 10105
Sector: Healthcare
Industry: Biotechnology
Full time employees: 217
$CBMG buy more doomers!!!
$CBMG i am trading for a better future!
$CBMG it can go lower
$CBMG never selling
$CBMG what caused the sell off in an otherwise good tech market today?
$CBMG When in doubt...
$CBMG Green today if ya buy
$CBMG Same thing
different day
$CBMG Buying again tomorrow.
$CBMG who here can't stand the CEO?